| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-1,442 | -934 | 173 | -1,974 | -4,382 | -6,925 | -3,808 | -1,730 | -1,328 |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization expense | ||||||||
849 | 593 | 588 | 524 | 481 | 387 | 342 | 318 | 294 |
Stock-based compensation expense | ||||||||
4,540 | 3,464 | 3,269 | 3,238 | 2,750 | 3,245 | 2,586 | 723 | 567 |
Noncash interest expense | ||||||||
- | - | - | - | - | 0 | 0 | 0 | 14 |
Provision for bad debt | ||||||||
21 | - | - | - | - | - | - | - | - |
Deferred rent | ||||||||
51 | 56 | 57 | 28 | -6 | -18 | 6 | -177 | -148 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
3,462 | 2,305 | 5,818 | -1,287 | 8,396 | -4,329 | 4,070 | -2,458 | 5,483 |
Prepaid expenses and other current assets | ||||||||
94 | 3,855 | 1,781 | 131 | -158 | -189 | -327 | 1,094 | 285 |
Other assets | ||||||||
4 | - | - | - | - | - | - | - | - |
Accounts payable | ||||||||
3,983 | 305 | 5,003 | -3,102 | 4,631 | 2,538 | -799 | 582 | 2,611 |
Accrued expenses and other current liabilities | ||||||||
-489 | 6,712 | 3,061 | -687 | 1,040 | -43 | 504 | -1,612 | 2,475 |
Deferred revenue | ||||||||
76 | -66 | -194 | 91 | 230 | - | - | - | - |
Deferred revenue | ||||||||
- | - | - | - | - | - | - | - | 144 |
Net cash provided by (used in) operating activities | ||||||||
3,927 | 3,956 | 4,299 | -360 | -3,482 | 4,109 | -5,007 | -156 | -843 |
Cash flows from investing activities: | ||||||||
Acquisition of property and equipment, including costs capitalized for development of internal-use software | ||||||||
885 | 777 | 646 | 885 | 667 | 1,192 | 1,081 | 741 | 654 |
Net cash used in investing activities | ||||||||
-885 | -777 | -646 | -885 | -667 | -1,192 | -1,081 | -741 | -654 |
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | ||||||||
1,364 | 926 | 1,173 | 649 | 234 | 8 | 276 | 9 | 568 |
Proceeds from borrowings on line of credit | ||||||||
- | - | - | - | - | 0 | 0 | 10,000 | 12,729 |
Repayments of borrowings on line of credit | ||||||||
- | - | - | - | - | 0 | 6,983 | 8,791 | 8,955 |
Repayments of term loan | ||||||||
- | - | - | - | - | 0 | 0 | 0 | 2,625 |
Payments of initial public offering costs | ||||||||
- | - | - | - | - | 0 | 3,191 | 518 | 4 |
Net cash provided by financing activities | ||||||||
1,364 | 926 | 1,173 | 649 | 234 | 8 | 42,415 | 700 | 1,713 |
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||||
4,406 | 4,105 | 4,826 | -596 | -3,915 | 2,925 | 36,327 | -197 | 216 |
Supplemental disclosure of noncash investing and financing information: | ||||||||
Deferred initial public offering costs included in accounts payable or accrued expenses | ||||||||
- | - | - | - | - | - | - | 1,862 | 1,328 |
Accretion of redeemable convertible preferred stock to redemption value | ||||||||
- | - | - | - | - | 0 | 0 | 26,402 | 11,013 |